Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Pfizer
Pfizer
Pfizer
Jacobio Pharmaceuticals Co., Ltd.
MacroGenics
Allist Pharmaceuticals, Inc.
Sumitomo Pharma America, Inc.
AstraZeneca
Celgene